Table 2. Association between PRDX3 expression and clinicopathological characteristics in LSCC patients.
| Variable | PRDX3 expression | P value | ||
|---|---|---|---|---|
| Grade I | Grade II | Grade III | ||
| Age | ||||
| ≤65 years | 12 | 9 | 4 | 0.929 |
| >65 years | 11 | 7 | 5 | |
| Sex | ||||
| Male | 21 | 15 | 9 | 1.000 |
| Female | 2 | 1 | 0 | |
| Tobacco smoking | ||||
| Ever | 20 | 15 | 9 | 0.657 |
| Never | 3 | 1 | 0 | |
| Primary tumor location | ||||
| Supraglottic cancer | 2 | 3 | 4 | 0.031 |
| Glottic cancer | 20 | 12 | 3 | |
| Infraglottic cancer | 1 | 1 | 2 | |
| T-category | ||||
| 1-2 | 15 | 8 | 3 | 0.245 |
| 3-4 | 8 | 8 | 6 | |
| N-category | ||||
| 0 | 21 | 10 | 5 | 0.032 |
| 1-3 | 2 | 6 | 4 | |
| Stage | ||||
| I-II | 16 | 5 | 2 | 0.017 |
| III-IV | 7 | 11 | 7 | |
| Histological grade | ||||
| G1 | 23 | 0 | 0 | 0.000 |
| G2 | 0 | 16 | 0 | |
| G3 | 0 | 0 | 9 | |